In autosomal dominant polycystic kidney disease (ADPKD), a minority of patients lack functional TRPP2 [23], and pregnenolone sulfate is not likely to have therapeutic value in the absence of the TRPM3/TRPP2-dependent channel. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.